Characterization of Carbapenem Nonsusceptible Pseudomonas aeruginosa in Denmark: A Nationwide, Prospective Study
- 1 February 2014
- journal article
- research article
- Published by SAGE Publications in Microbial Drug Resistance
- Vol. 20 (1) , 22-29
Abstract
From January 1st 2011 through June 30th 2011, 116 nonreplicate, noncystic fibrosis-related Pseudomonas aeruginosa isolates with reduced carbapenem susceptibility were collected from 12 out of 13 Danish departments of clinical microbiology. The presence of acquired β-lactamases was assessed with combination tablet-diffusion methodology and polymerase chain reaction. In addition, antimicrobial susceptibility testing, an efflux pump inhibitor assay, and pulsed-field gel electrophoresis (PFGE) were performed. Isolates producing acquired β-lactamases were further investigated by serotyping and multi locus sequence typing. Eight isolates produced the metallo-β-lactamase (MBL) VIM-2, and one isolate produced OXA-10 and VEB-1-like extended-spectrum beta-lactamase (ESBL). Phenotypic indications of derepressed AmpC and efflux pump were seen in 56 and 43 isolates, respectively. Overall, the results indicate that mutational factors related to permeability—often combined with derepressed, chromosomal AmpC—is the main factor behind carbapenem nonsusceptibility in Danish P. aeruginosa isolates. The ESBL producer and all the VIM producers belonged to international clones. PFGE revealed that most of the isolates were unrelated, but clonal spread was seen; the 116 isolates distributed in 97 PFGE types, with the largest cluster consisting of 4 isolates (including three isolates from the same hospital with 100% similarity). Thirty-two isolates were pair-wise related, while the remaining isolates were clonally unrelated, as were all nine ESBL/MBL producers.Keywords
This publication has 36 references indexed in Scilit:
- Kinetic and Crystallographic Studies of Extended-Spectrum GES-11, GES-12, and GES-14 β-LactamasesAntimicrobial Agents and Chemotherapy, 2012
- InVitroActivity Studies of Doripenem and Two Other Carbapenems Tested AgainstPseudomonas aeruginosaand Other Non-Fermentative BacilliJournal of Chemotherapy, 2011
- Most Multidrug-Resistant Pseudomonas aeruginosa Isolates from Hospitals in Eastern France Belong to a Few Clonal TypesJournal of Clinical Microbiology, 2011
- Metallo-β-lactamases: a last frontier for β-lactams?The Lancet Infectious Diseases, 2011
- Overexpression of AmpC and Efflux Pumps in Pseudomonas aeruginosa Isolates from Bloodstream Infections: Prevalence and Impact on Resistance in a Spanish Multicenter StudyAntimicrobial Agents and Chemotherapy, 2011
- Development of a set of multiplex PCR assays for the detection of genes encoding important β-lactamases in EnterobacteriaceaeJournal of Antimicrobial Chemotherapy, 2010
- Outbreak of Pseudomonas aeruginosa Infections with PER-1 Extended-Spectrum β-Lactamase in Warsaw, Poland: Further Evidence for an International Clonal ComplexJournal of Clinical Microbiology, 2007
- Emergence and Dissemination of BEL-1-Producing Pseudomonas aeruginosa Isolates in BelgiumAntimicrobial Agents and Chemotherapy, 2007
- Multiplex PCR for rapid detection of genes encoding acquired metallo- -lactamasesJournal of Antimicrobial Chemotherapy, 2006
- Development of a Multilocus Sequence Typing Scheme for the Opportunistic Pathogen Pseudomonas aeruginosaJournal of Clinical Microbiology, 2004